Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Partillion Bioscience is an early-stage life science company developing a functional single-cell analysis platform.
Aavogen is a biotech startup that develops gene therapeutics for muscle wasting diseases.
Viora Health is a tech-enabled human centered program that wraps around the care management to engage patients in their own communities
Lactiga is a biotherapeutics company advancing its patented biologics to transform the anti-infective sector and protect vulnerable patients
Remote Therapeutic Monitoring for Mental Health Treatments
Perfuiso markets an FDA cleared non-invasive surgical imaging device.
NovaSignal is a medical technology company commercializing a robotic cerebral ultrasound system.
custom aptamer development services
Omniose is an early stage biotechnological company.
BetterAge provides a personalized, web-based program to help individuals improve health and well-being.
SpineX is a bioelectric medtech company that develops non-invasive neuromodulation devices.
Satio brings a dried blood spot and whole blood collection to the consumer; simple, painless, and clean using patches.
InformAI delivers AI-enabled clinical solution focused on oncology and diagnostic imaging to improve patient outcomes.
Resvita Bio develops and manufactures engineered probiotics for use in treatment if skin related diseases including cancer.
Redefining Sample Preparation, Revolutionizing Genomics
Kinoxis Therapeutics is a biotechnology company that develops a range of novel therapeutic compounds.
Precision Epigenomics is a molecular diagnostic company that develops molecular diagnostic assays for cancer diagnosis.
Fauna Bio is a biotechnology company leveraging the science of hibernation to improve healthcare for humans.
Lasarrus develops devices for patients with chronic obstructive pulmonary disease.
TruDiagnostic is a biodata research company that offers epigenetic testing and research services.
Dignify Therapeutics is a drug development company focused on delivering novel drug therapies for bladder and bowel disorders in spinal.
Airway Therapeutics focuses on pulmonary research program of Cincinnati Children’s Hospital Medical Center for further development.
Stem Pharm's synthetic biomaterials support the optimization of cell expansion.
Drug Discovery and Biotechnology
National Institutes of Health has invested in 491 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
National Institutes of Health's top investment sectors include Biotechnology, Health Care, Medical, Pharmaceutical, Medical Device. The firm invests across 27 different industry categories.
Among tracked funding rounds, NovaSignal received $37.0M in a Series C round. National Institutes of Health's total known invested capital is $2.1B.
National Institutes of Health's average investment size is $5.3M across its portfolio of 491 companies.
Recent National Institutes of Health portfolio additions include Partillion Bioscience, Aavogen, Viora Health, Lactiga, Levl. These companies were founded in 2020 or later.